Home › Funds › Velan Capital Investment Management LP › VRCA

Velan Capital Investment Management LP position in VRCA

VERRICA PHARMACEUTICALS INC · Health Care

Velan Capital Investment Management LP reported holding 471,559 shares of VRCA (VERRICA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$2.9M, representing 1.85% of its reported portfolio and ranking #14 among its reported holdings. Velan Capital Investment Management LP has disclosed VRCA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)471.56K sh
Reported value held$2.89M
Portfolio Weight1.85%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's VRCA position evolved

Velan Capital Investment Management LP first disclosed a stake in VRCA in Q4 2025 at 471,559 shares (US$3.9M). Across 3 filings, Velan Capital Investment Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 471,559 shares valued at US$2.9M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 471.56K $3.92M New
Q1 2026 471.56K $2.49M Hold
Q2 2026 471.56K $2.89M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRCA and 13F data

VRCA (VERRICA PHARMACEUTICALS INC) is a Health Care company. 20 other funds we track also report a position in VRCA — the largest reported positions include Caligan Partners LP (US$5.7M), CANNELL CAPITAL LLC (US$4.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRCA

All VRCA fund holders →

FAQ

How long has Velan Capital Investment Management LP held VRCA?

Velan Capital Investment Management LP has disclosed VRCA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Velan Capital Investment Management LP's current position in VRCA?

As of Q2 2026, Velan Capital Investment Management LP holds 471.56K shares of VRCA (VERRICA PHARMACEUTICALS INC), valued at $2.89M, representing 1.85% of its reported portfolio and ranking #14.

Has Velan Capital Investment Management LP been buying or selling VRCA?

In the latest 13F filing (Q2 2026), Velan Capital Investment Management LP held unchanged its position in VRCA.

Which other funds hold VRCA?

Other major institutional holders of VRCA include Caligan Partners LP, CANNELL CAPITAL LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.